Overview
Nanoexpo is a biotech start-up that provides R&D services in bioengineering, specifically focusing on the design and manufacturing of enveloped and non-enveloped virus-like particles (VLPs). The company also offers services for producing polyclonal antibodies and designing antigens for vaccine development and diagnostic tests using various cell-based platforms. Additionally, they work with biological nanostructures capable of carrying genetic material.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-11-27. Active
58 1050 1764 1000 0024 6992 3979- 70 1050 1764 1000 0090 8106 1195
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 28, 2025 | Aid for research and development projects: industrial research | $80,175$80,175 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 29, 2021 | Aid for research and development projects: industrial research | $171.1K$171,118 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 29, 2021 | Aid for research and development projects: experimental development | $141.7K$141,736 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-03-01 | Zastosowanie nowoczesnych technik biotechnologicznych i bioinformatycznych do opracowywania cząstek wirusopodobnych w celach diagnostycznych i terapeutycznych. | $1.2M$1,162,487 | Fundusze Europejskie dla Pomorza 2021-2027 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Beata Marta Gromadzka (47) | 51 | $688.82 | 51% |
Mirosława Małgorzata Panasiuk (40) | 40 | $540.25 | 40% |
Others | 9 | $121.56 | 9% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Hybridovaxsp. z o.o. | 540.25 USD | 40% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Smart NanotechnologiesS.A. | $1,162,260.91 | smartnanotechnologies.com.pl | ||
| NoctilucaS.A. | $1,013,963.40 | noctiluca.eu | ||
| Nano-Tech Polskasp. z o.o. + limited partnership | $890,880.64 | nano-tech.pl | ||
| COS Lab Private Labelsp. z o.o. | $862,358.84 | coslab.pl | ||
| Instytut Roślin Leczniczych i Użytkowychsp. z o.o. | $703,256.70 | coslab.pl | ||
| Polcolorsp. z o.o. | $215,751.49 | polcolor.com | ||
| QNA TechnologyS.A. | $227,021.60 | qnatechnology.com | ||
| Alpha Powderssp. z o.o. | $202,553.98 | alphapowders.eu |
FAQ
Last updated: 2026-08-06